John D. Carpten, PhD, FAACR, to Join the AACR Board of Directors
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced that John D. Carpten, PhD, FAACR, has been...
Search/Filter
Loading...
American Association for Cancer Research Inaugurates New Leadership at Virtual AACR Annual Business Meeting of Members 2021
David A. Tuveson, MD, PhD, FAACR, inaugurated as President PHILADELPHIA — The American Association for Cancer Research (AACR) welcomes...
Healthy Lifestyle May Offset Risk of Lethal Prostate Cancer in Men With High Genetic Risk
PHILADELPHIA – Men who had a high genetic risk of developing prostate cancer were less likely to develop a...
Copanlisib-Rituximab Combination Cuts Lymphoma Progression or Death by Nearly Half in CHRONOS-3 Trial
PHILADELPHIA – A combination of copanlisib (Aliqopa) and rituximab led to a 48 percent reduction in the risk of...
Immunotherapy Response Prediction Using Tumor Mutational Burden May Differ Between Men and Women With Melanoma
PHILADELPHIA – Tumor mutational burden (TMB) was an accurate predictor of response to treatment with immune checkpoint inhibitors for...
Liquid Biopsy Augments MRI for Predicting Response to Neoadjuvant Treatment in Patients With Breast Cancer
PHILADELPHIA – A liquid biopsy test to assess plasma cell-free DNA (cfDNA) integrity could improve the accuracy of magnetic...
Personalized Cancer Vaccine Given After Adjuvant Therapy Safe, Shows Early Efficacy in Multiple Tumor Types
PHILADELPHIA – Treatment with the neoantigen cancer vaccine PGV-001 following standard-of-care adjuvant therapy was well tolerated and showed potential...
CREB1 Identified as Potential Therapeutic Target for the Treatment of Pancreatic Cancer
PHILADELPHIA – Preclinical experiments using cell lines, genetic mouse models, and human pancreatic tumor tissue identified the transcription factor...
Early-onset Colorectal Cancers from Patients of Different Races May Exhibit Distinct Genetic Features
PHILADELPHIA – Racial differences in genetic mutations were observed among early-onset colorectal cancers (CRC), according to data presented during...
Unselected Autologous Tumor Infiltrating Lymphocyte Therapy Shows Early Promise in Patients With Metastatic Melanoma
PHILADELPHIA – Treatment with unselected autologous tumor infiltrating lymphocytes (TILs) showed early clinical efficacy among patients with advanced melanoma,...